Real-World Evidence for the Safety of Ipragliflozin in Elderly Japanese Patients With Type 2 Diabetes Mellitus (STELLA-ELDER): Final Results of a Post-Marketing Surveillance Study
Expert Opinion on Pharmacotherapy - United Kingdom
doi 10.1080/14656566.2016.1219341
Full Text
Open PDFAbstract
Available in full text
Date
August 31, 2016
Authors
Publisher
Informa UK Limited